Skip to main navigation Skip to main content Skip to footer For Medicare For Providers For Brokers For Employers Español For Individuals & Families: For Individuals & Families Medical Dental Other Supplemental Explore coverage through work How to Buy Health Insurance Types of Dental Insurance Open Enrollment vs. Special Enrollment See all topics Shop for Medicare plans Member Guide Find a Doctor Log in to myCigna
Home Knowledge Center Wellness Library ipilimumab

ipilimumab

Pronunciation: IP i LIM ue mab

Brand: Yervoy

What is the most important information I should know about ipilimumab?

What is the most important information I should know about ipilimumab?

Serious and sometimes fatal reactions may occur during treatment with ipilimumab, or months after your last dose. Call your doctor at once if you have: chest pain, cough, shortness of breath, vision changes, severe muscle pain or weakness, diarrhea and severe stomach pain, blood in your stools, little or no urinating, swelling, bruising or bleeding, dark urine, yellowing of the skin or eyes, confusion, hallucinations, a seizure, skin blistering, or a hormonal disorder (frequent headaches, feeling light-headed, increased thirst or urination, feeling cold, weight gain or loss).

What is ipilimumab?

What is ipilimumab?

Ipilimumab is a cancer medicine that is used alone or in combination with other medicines to treat certain types of cancer such as:

  • skin cancer (melanoma);
  • non-small cell lung cancer (NSCLC);
  • pleural mesothelioma (cancer that affects the lining of the lungs and chest wall);
  • squamous cell cancer of the esophagus;
  • kidney cancer;
  • liver cancer; or
  • colorectal cancer that has certain specific DNA mutations.

Ipilimumab is often given when the cancer has spread to other parts of the body, or cannot be surgically removed, or has come back after prior treatment.

Ipilimumab is given for NSCLC only if your tumor tests positive for "PD-L1" and does not have an abnormal "EGFR" or "ALK" (a specific genetic marker).

Ipilimumab may also be used for purposes not listed in this medication guide.

What should I discuss with my healthcare provider before receiving ipilimumab?

What should I discuss with my healthcare provider before receiving ipilimumab?

You should not receive ipilimumab if you are allergic to it.

Tell your doctor if you have ever had:

  • liver problems;
  • an autoimmune disorder (lupus, sarcoidosis, Crohn's disease, ulcerative colitis);
  • an organ transplant or stem cell transplant; or
  • a nerve-muscle disorder, such as myasthenia gravis, or Guillain-Barre syndrome.

You may need to have a negative pregnancy test before starting this treatment.

Ipilimumab may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 3 months after your last dose. Tell your doctor if you become pregnant.

If you are pregnant, your name may be listed on a pregnancy registry to track the effects of ipilimumab on the baby.

Do not breastfeed while using this medicine, and for at least 3 months after your last dose.

Ipilimumab is not approved for use by anyone younger than 12 years old. For some types of cancer, ipilimumab is used only in adults.

How is ipilimumab given?

How is ipilimumab given?

Ipilimumab is given as an infusion into a vein. A healthcare provider will give you this injection.

This medicine must be given slowly, and the infusion can take 30-90 minutes to complete.

Ipilimumab is usually given once every 3 to 6 weeks. Your other cancer medications may be given more often. Your doctor will determine how long to treat you with all medicines.

You may be given other medications to treat or prevent certain side effects.

You may need frequent medical tests and your cancer treatments may be delayed based on the results.

What happens if I miss a dose?

What happens if I miss a dose?

Call your doctor for instructions if you miss a chemotherapy appointment.

What happens if I overdose?

What happens if I overdose?

Since ipilimumab is given by a healthcare professional in a medical setting, an overdose is unlikely to occur.

What should I avoid while receiving ipilimumab?

What should I avoid while receiving ipilimumab?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

What are the possible side effects of ipilimumab?

What are the possible side effects of ipilimumab?

Get emergency medical help if you have signs of an allergic reaction (hives, difficult breathing, swelling in your face or throat) or a severe skin reaction (fever, sore throat, burning eyes, skin pain, red or purple skin rash with blistering and peeling).

Some side effects may occur during the injection. Tell your caregiver if you feel dizzy, light-headed, short of breath, itchy, tingly, chilled, or feverish.

Serious and sometimes fatal reactions may occur during treatment with ipilimumab or months after your last dose.. Call your doctor right away if you have symptoms such as:

  • severe or ongoing diarrhea, severe stomach pain, bloody or tarry stools;
  • fever, swollen glands, body aches;
  • new or worsening skin rash, itching, or blistering;
  • painful sores in mouth or nose, throat, or genital area;
  • chest pain, irregular heartbeats;
  • severe muscle weakness, ongoing pain in your muscles or joints;
  • numbness or tingling in your hands or feet;
  • vision problems, eye pain or redness;
  • lung problems --new or worsening cough, chest pain, feeling short of breath;
  • kidney problems --little or no urination, swelling in your feet or ankles, blood in your urine;
  • liver problems --right-sided upper stomach pain, tiredness, bruising or bleeding, dark urine, yellowing of your skin or eyes;
  • signs of a hormonal disorder --frequent or unusual headaches, lack of energy, dizziness, fainting, mood or behavior changes, increased thirst or urination, feeling cold, weight gain, or weight loss; or
  • symptoms of brain swelling --confusion, headache, memory problems, hallucinations, neck stiffness, drowsiness, seizure (convulsions).

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common side effects may include:

  • fever, cough, shortness of breath;
  • nausea, vomiting, stomach pain, loss of appetite;
  • diarrhea, constipation;
  • weight loss;
  • hormonal problems;
  • rash or itching;
  • headache, dizziness, tiredness;
  • sleep problems (insomnia); or
  • pain in your muscles, joints, or bones.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect ipilimumab?

What other drugs will affect ipilimumab?

Other drugs may affect ipilimumab, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Where can I get more information?

Where can I get more information?

Your pharmacist can provide more information about ipilimumab.

This information does not replace the advice of a doctor. Healthwise, Incorporated, disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. Learn how we develop our content.

Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.

<cipublic-spinner variant="large"><span>Loading…</span></cipublic-spinner>

Page Footer

I want to...

Get an ID card File a claim View my claims and EOBs Check coverage under my plan See prescription drug list Find an in-network doctor, dentist, or facility Find a form Find 1095-B tax form information View the Cigna Glossary Contact Cigna

Audiences

Individuals and Families Medicare Employers Brokers Providers

Secure Member Sites

myCigna member portal Health Care Provider portal Cigna for Employers Client Resource Portal Cigna for Brokers

The Cigna Group Information

About The Cigna Group Company Profile Careers Newsroom Investors Suppliers The Cigna Group Third Party Administrators International Evernorth

 Cigna. All rights reserved.

Privacy Legal Product Disclosures Cigna Company Names Customer Rights Accessibility Non-Discrimination Notice Language Assistance [PDF] Report Fraud Sitemap Cookie Settings

Disclaimer

Individual and family medical and dental insurance plans are insured by Cigna Health and Life Insurance Company (CHLIC), Cigna HealthCare of Arizona, Inc., Cigna HealthCare of Illinois, Inc., Cigna HealthCare of Georgia, Inc., Cigna HealthCare of North Carolina, Inc., Cigna HealthCare of South Carolina, Inc., and Cigna HealthCare of Texas, Inc. Group health insurance and health benefit plans are insured or administered by CHLIC, Connecticut General Life Insurance Company (CGLIC), or their affiliates (see a listing of the legal entities that insure or administer group HMO, dental HMO, and other products or services in your state). Accidental Injury, Critical Illness, and Hospital Care plans or insurance policies are distributed exclusively by or through operating subsidiaries of Cigna Corporation, are administered by Cigna Health and Life Insurance Company, and are insured by either (i) Cigna Health and Life Insurance Company (Bloomfield, CT); (ii) Life Insurance Company of North America (“LINA”) (Philadelphia, PA); or (iii) New York Life Group Insurance Company of NY (“NYLGICNY”) (New York, NY), formerly known as Cigna Life Insurance Company of New York. The Cigna name, logo, and other Cigna marks are owned by Cigna Intellectual Property, Inc. LINA and NYLGICNY are not affiliates of Cigna.

All insurance policies and group benefit plans contain exclusions and limitations. For availability, costs and complete details of coverage, contact a licensed agent or Cigna sales representative. This website is not intended for residents of New Mexico.

Selecting these links will take you away from Cigna.com to another website, which may be a non-Cigna website. Cigna may not control the content or links of non-Cigna websites. Details